CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit Prior to Exploration Stage [Member]	Accumulated Deficit During Exploration Stage [Member]
Balance at Dec. 31, 2020	$ (47,829,437)	$ 183,939	$ 128	$ 74,008,636	$ (20,009,496)	$ (102,012,644)
Balance (in shares) at Dec. 31, 2020		183,938,549	128,000
Shares issued upon conversion of Series B Preferred Stock	$ 8,380	$ 15,805	$ (223)	(7,202)
Shares issued upon conversion of Series B Preferred Stock (in shares)		15,805,934	(223,000)
Shares issued as part of liability settlement (in shares)		1,162,791
Issuance of shares for debt issuance cost		$ 58,140
Issuance of shares of common stock for consulting services (in shares)	9,528,689	3,836,475
Beneficial conversion feature on Convertible Series B Preferred Stock	$ 225,137			225,137
Deemed dividend from beneficial conversion feature on Convertible Series B Preferred Stock	(225,137)			(225,137)
Shares of Series B Preferred Stock issued in private placement	385,000		$ 352	384,648
Shares of Series B Preferred Stock issued in private placement (in shares)			352,136
Shares issued for cashless exercise of options		$ 3,836		(3,836)
Shares issued for cashless exercise of options (in shares)		3,836,475
Shares issued for employee bonus	58,140	$ 1,163		56,977
Shares issued for employee bonus (in shares)		1,162,791
Stock option compensation expense	155,058			155,058
Net income (loss)	(2,700,201)					(2,700,201)
Balance at Sep. 30, 2021	(49,923,060)	$ 204,743	$ 257	74,594,281	(20,009,496)	(104,712,845)
Balance (in shares) at Sep. 30, 2021		204,743,749	257,136
Balance at Jun. 30, 2021	(49,251,882)	$ 195,105	$ 176	74,256,128	(20,009,496)	(103,693,795)
Balance (in shares) at Jun. 30, 2021		195,105,088	176,136
Shares issued upon conversion of Series B Preferred Stock	700	$ 9,638	$ (95)	(8,843)
Shares issued upon conversion of Series B Preferred Stock (in shares)		9,638,661	(95,000)
Beneficial conversion feature on Convertible Series B Preferred Stock	112,525			112,525
Deemed dividend from beneficial conversion feature on Convertible Series B Preferred Stock	(112,525)			(112,525)
Shares of Series B Preferred Stock issued in private placement	200,000		$ 176	199,824
Shares of Series B Preferred Stock issued in private placement (in shares)			176,000
Stock option compensation expense	147,172			147,172
Net income (loss)	(1,019,050)					(1,019,050)
Balance at Sep. 30, 2021	(49,923,060)	$ 204,743	$ 257	74,594,281	(20,009,496)	(104,712,845)
Balance (in shares) at Sep. 30, 2021		204,743,749	257,136
Balance at Dec. 31, 2021	$ (50,400,882)	$ 217,654	$ 262	74,686,581	(20,009,496)	(105,295,883)
Balance (in shares) at Dec. 31, 2021		217,655,150	262,000
Shares issued upon conversion of Series B Preferred Stock		$ 96,798	$ (262)	(96,536)
Shares issued upon conversion of Series B Preferred Stock (in shares)	20,164,153	96,797,312	(262,000)
Shares issued as part of liability settlement	$ 128,445	$ 22,222		106,223
Shares issued as part of liability settlement (in shares)		22,222,221
Forgiveness of related party liabilities	1,991,061			1,991,061
Shares issued to BMI Minerals Company	62,000	$ 20,000		42,000
Shares issued to BMI Minerals Company (in shares)		20,000,000
Share issuance cost	(20,000)			(20,000)
Issuance of shares for debt issuance cost	1,740	$ 300		1,440
Issuance of shares for debt issuance cost (in shares)		300,000
Issuance of shares of common stock for consulting services	$ 70,000	$ 10,000		60,000
Issuance of shares of common stock for consulting services (in shares)	70,000	10,000,000
Beneficial conversion feature on Convertible Series B Preferred Stock	$ 77,876			77,876
Deemed dividend from beneficial conversion feature on Convertible Series B Preferred Stock	(77,876)			(77,876)
Shares of Series B Preferred Stock issued in private placement	$ 75,000		$ 78	74,922
Shares of Series B Preferred Stock issued in private placement (in shares)			78,000
Shares issued for cashless exercise of options (in shares)	0
Stock option compensation expense	$ 92,006			92,006
Net income (loss)	(1,698,574)					(1,698,574)
Balance at Sep. 30, 2022	(49,699,204)	$ 366,974	$ 78	76,937,697	(20,009,496)	(106,994,457)
Balance (in shares) at Sep. 30, 2022		366,974,683	78,000
Balance at Jun. 30, 2022	(52,047,403)	$ 285,786	$ 164	74,861,487	(20,009,496)	(107,185,344)
Balance (in shares) at Jun. 30, 2022		285,787,382	164,000
Shares issued upon conversion of Series B Preferred Stock		$ 43,410	$ (86)	(43,324)
Shares issued upon conversion of Series B Preferred Stock (in shares)		43,409,524	(86,000)
Shares issued as part of liability settlement	74,667	$ 17,778		56,889
Shares issued as part of liability settlement (in shares)		17,777,777
Forgiveness of related party liabilities	1,991,061			1,991,061
Shares issued to BMI Minerals Company	62,000	$ 20,000		42,000
Shares issued to BMI Minerals Company (in shares)		20,000,000
Share issuance cost	(20,000)			(20,000)
Beneficial conversion feature on Convertible Series B Preferred Stock	51,929			51,929
Deemed dividend from beneficial conversion feature on Convertible Series B Preferred Stock	(51,929)			(51,929)
Stock option compensation expense	49,584			49,584
Net income (loss)	190,887				190,887
Balance at Sep. 30, 2022	$ (49,699,204)	$ 366,974	$ 78	$ 76,937,697	$ (20,009,496)	$ (106,994,457)
Balance (in shares) at Sep. 30, 2022		366,974,683	78,000